Last update 01 Nov 2024

Xinghe Co., Ltd

Overview

Tags

Endocrinology and Metabolic Disease
Digestive System Disorders
Other Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
PPARα(Peroxisome proliferator-activated receptor α)1

Related

1
Drugs associated with Xinghe Co., Ltd
Pemafibrate
Target
PPARα
Mechanism
PPARα agonists
Active Org.
Kowa Research Institute, Inc. [+3]
Originator Org.
Kowa Co., Ltd.Kowa Co., Ltd.
Active Indication
Hyperlipidemias [+5]
Inactive Indication
Diabetes Mellitus [+2]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
JP
First Approval Date03 Jul 2017
2
Clinical Trials associated with Xinghe Co., Ltd
CTR20220681 / CompletedPhase 1
一项在中国健康成年男性志愿者中进行的K-877的单中心、开放性、多剂量、平行分组的药代动力学研究
[Translation] A single-center, open-label, multiple-dose, parallel-group pharmacokinetic study of K-877 in healthy adult male volunteers from China
CTR20211983 / CompletedPhase 3
一项3期多中心、安慰剂和活性对照、随机、双盲、为期12周的评估K-877在中国高TG和低HDL-C患者中的有效性和安全性的研究
[Translation] A Phase 3, multicenter, placebo- and active-controlled, randomized, double-blind, 12-week study to evaluate the efficacy and safety of K-877 in Chinese patients with high TG and low HDL-C
100 Clinical Results associated with Xinghe Co., Ltd
Login to view more data
0 Patents (Medical) associated with Xinghe Co., Ltd
Login to view more data
100 Deals associated with Xinghe Co., Ltd
Login to view more data
100 Translational Medicine associated with Xinghe Co., Ltd
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Pemafibrate
 ( PPARα )		Hyperlipidemias
More
Phase 3
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free